Dezeen Showroom: Italian brand Fiandre aimed to create a "vocabulary of surfaces" with the Lexicon tile collection, featuring eight high-tech stone- and marble-inspired designs. Both atmospheric, ...

Lexicon Pharmaceuticals is positioned for a potential turnaround with three key drug programs and recent partnerships, despite a challenging history. LXRX's sotagliflozin faces uncertain FDA approval ...

Community driven content discussing all aspects of software development from DevOps to design patterns. To use any of these JVM options, simply append them as text after the java runtime command. For ...

Lexicon eligible to receive up to $1 billion in upfront and development, regulatory and sales milestone payments, including $75 million in upfront and near-term milestone payments THE WOODLANDS, Texas ...

Lexicon Pharmaceuticals’ pursuit of the last word in obesity candidates has attracted Novo Nordisk. The Danish drugmaker is betting $75 million in upfront and near-term milestone payments to secure ...

Lexicon Pharmaceuticals is yet again defending a mixed set of data on its non-opioid pain prospect. The biotech focused on low-dose results from its latest phase 2 trial, rather than the overall ...

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) shares are trading lower by 42% to 40 cents Monday morning. The company earlier announced topline results from its PROGRESS Phase 2b study evaluating ...

Despite not differentiating itself from placebo, the Texas-based company said it plans to push pilavapadin into Phase III trials before long. In a setback in the race to develop non-opioid painkillers ...

Lexicon expects delay in FDA feedback on additional data for its diabetes drug Lexicon Pharmaceuticals said on Monday the U.S. Food and Drug Administration requires more time to review the company's ...

Community driven content discussing all aspects of software development from DevOps to design patterns. The latest long-term support (LTS) release of the JDK is Java 21, which was released in ...